According to the Summary of Product Characteristics (SmPC), these include: Nausea (very common) Vomiting (common) Diarrhoea (very common) Constipation (common) Abdominal pain or discomfort (common) Decreased appetite (very common) These symptoms typically diminish over time as the body adjusts to the medication
Yan J, Young ME, Cui L, Lopaschuk GD, Liao R, Tian R (2009) Increased glucose uptake and oxidation in mouse hearts prevent high fatty acid oxidation but cause cardiac dysfunction in diet-induced obesity
Perinatal exposure to low-dose decabromodiphenyl ethane increased the risk of obesity in male mice offspring
The ultrasound option is unlikely to be available in ambulatory dental settings
The pharmacological opposition makes the combination less predictable
Consumers, researchers, and institutions are advised to consult directly with the manufacturer or appropriate regulatory authorities for any questions regarding legality, usage restrictions, or safety protocols before purchasing or handling any research compound
